Conference report--gene therapy and lung cancer--no time to wait.
作者信息
Mariani Sara M
机构信息
Medscape General Medicine.
出版信息
MedGenMed. 2004 Jul 16;6(3):21.
Abstract
摘要
相似文献
1
Conference report--gene therapy and lung cancer--no time to wait.会议报告——基因治疗与肺癌——刻不容缓
MedGenMed. 2004 Jul 16;6(3):21.
2
Promising results reported for lung cancer gene therapy.肺癌基因治疗报告取得了有前景的结果。
Lancet. 1996 Sep 7;348(9028):671. doi: 10.1016/S0140-6736(05)65076-3.
3
Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.晚期肺癌中自杀基因治疗恶性胸腔积液的管理：病例系列和文献复习。
Cancer Gene Ther. 2012 Sep;19(9):593-600. doi: 10.1038/cgt.2012.36. Epub 2012 Jun 29.
4
5
[Non surgical new treatment modalities for lung cancer].[肺癌的非手术新治疗方式]
Nihon Geka Gakkai Zasshi. 2002 Feb;103(2):217.
6
[Does molecular targeted therapy change the treatment for lung cancer?].[分子靶向治疗是否改变了肺癌的治疗方式？]
Fukuoka Igaku Zasshi. 2004 Sep;95(9):205-9.
7
Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway.初级医疗对肺癌两周等待计划的利用不足及其对紧急转诊途径的影响。
Br J Cancer. 2005 Oct 17;93(8):905-8. doi: 10.1038/sj.bjc.6602798.
8
Mesothelioma: an inviting but challenging target for gene therapy.间皮瘤：基因治疗中一个诱人但具有挑战性的靶点。
Am J Respir Cell Mol Biol. 2010 Apr;42(4):383-4. doi: 10.1165/rcmb.2010-0071ED.
9
Gene therapy for mesothelioma and lung cancer.间皮瘤和肺癌的基因治疗。
Am J Respir Cell Mol Biol. 2010 Apr;42(4):385-93. doi: 10.1165/rcmb.2010-0026RT. Epub 2010 Feb 16.
10
Immunotherapy for lung cancer.肺癌免疫疗法。
Proc Am Thorac Soc. 2009 Apr 15;6(2):224-32. doi: 10.1513/pats.200806-048LC.
本文引用的文献
1
Modified adenoviruses for cancer gene therapy.用于癌症基因治疗的修饰腺病毒。
Int J Cancer. 2004 Jul 1;110(4):475-80. doi: 10.1002/ijc.20129.
2
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.瘤内注射过表达CCL21的树突状细胞可产生全身抗肿瘤反应并赋予肿瘤免疫。
Clin Cancer Res. 2004 Apr 15;10(8):2891-901. doi: 10.1158/1078-0432.ccr-03-0380.
3
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.粒细胞-巨噬细胞集落刺激因子基因修饰的自体肿瘤疫苗用于非小细胞肺癌治疗
J Natl Cancer Inst. 2004 Feb 18;96(4):326-31. doi: 10.1093/jnci/djh028.
4
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.在手术减瘤前使用β-干扰素进行免疫基因治疗可延缓恶性间皮瘤小鼠模型的复发并提高生存率。
J Thorac Cardiovasc Surg. 2004 Jan;127(1):123-30. doi: 10.1016/j.jtcvs.2003.08.034.
5
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells.人树突状细胞中CCL-21/二级淋巴组织趋化因子的过表达增强了对淋巴细胞和抗原呈递细胞的趋化活性。
Mol Cancer. 2003 Nov 2;2:35. doi: 10.1186/1476-4598-2-35.
6
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.白细胞介素-7基因修饰的树突状细胞可减轻自发性小鼠支气管肺泡细胞癌的肺部肿瘤负担。
Hum Gene Ther. 2003 Nov 1;14(16):1511-24. doi: 10.1089/104303403322495025.
7
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer.GVAX（GMCSF基因修饰肿瘤疫苗）用于晚期非小细胞肺癌
J Control Release. 2003 Aug 28;91(1-2):225-31. doi: 10.1016/s0168-3659(03)00210-4.
8
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.SLC/CCL21介导的抗肿瘤反应需要IFNγ、MIG/CXCL9和IP-10/CXCL10。
Mol Cancer. 2003 Apr 15;2:22. doi: 10.1186/1476-4598-2-22.
9
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.野生型腺病毒在局部注射人异种移植肿瘤后，瘤内传播受限：病毒在晚期时间点持续存在并发生全身扩散。
Hum Gene Ther. 2003 Mar 20;14(5):425-33. doi: 10.1089/104303403321467199.
10
Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models.
Methods Mol Med. 2003;75:711-22. doi: 10.1385/1-59259-324-0:711.
Zotero 插件